These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19628751)

  • 21. Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
    Mueller M; Yuan J; McCann UD; Hatzidimitriou G; Ricaurte GA
    Int J Neuropsychopharmacol; 2013 May; 16(4):791-801. PubMed ID: 22824226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
    Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F
    Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion.
    Perfetti X; O'Mathúna B; Pizarro N; Cuyàs E; Khymenets O; Almeida B; Pellegrini M; Pichini S; Lau SS; Monks TJ; Farré M; Pascual JA; Joglar J; de la Torre R
    Drug Metab Dispos; 2009 Jul; 37(7):1448-55. PubMed ID: 19349378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
    Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.
    Neudörffer A; Mueller M; Martinez CM; Mechan A; McCann U; Ricaurte GA; Largeron M
    Chem Res Toxicol; 2011 Jun; 24(6):968-78. PubMed ID: 21557581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.
    Miller RT; Lau SS; Monks TJ
    Eur J Pharmacol; 1997 Apr; 323(2-3):173-80. PubMed ID: 9128836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.
    Monks TJ; Jones DC; Bai F; Lau SS
    Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.
    Bai F; Jones DC; Lau SS; Monks TJ
    Chem Res Toxicol; 2001 Jul; 14(7):863-70. PubMed ID: 11453733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ("ecstasy") from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors.
    Martinez CM; Neudörffer A; Largeron M
    Org Biomol Chem; 2012 May; 10(18):3739-48. PubMed ID: 22456797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture.
    Walker TM; Davenport-Jones JE; Fox RM; Atterwill CK
    Cell Biol Toxicol; 1999 Jun; 15(3):137-42. PubMed ID: 10580546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
    Chu T; Kumagai Y; DiStefano EW; Cho AK
    Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of 3,4-methylenedioxymethamphetamine and its five main metabolites in rat urine by solid-phase extraction and high performance liquid chromatography with on line mass spectrometry.
    Menet MC; Fonsart J; Hervé F; Fompeydie D; Galliot-Guilley M; Noble F; Scherrmann JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2905-10. PubMed ID: 20843750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):119-24. PubMed ID: 18829400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.
    Escubedo E; Abad S; Torres I; Camarasa J; Pubill D
    Neurochem Int; 2011 Jan; 58(1):92-101. PubMed ID: 21074589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of neurotoxic thioether metabolites of 3,4-(+/-)-methylenedioxymethamphetamine in rat brain.
    Erives GV; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):284-91. PubMed ID: 17906065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
    Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
    Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys.
    Banks ML; Sprague JE; Kisor DF; Czoty PW; Nichols DE; Nader MA
    Drug Metab Dispos; 2007 Oct; 35(10):1840-5. PubMed ID: 17640955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.